by Stacey Johnson | Nov 29, 2024
Are you familiar with the Gartner Hype Cycle? It’s a way of separating reality from hype when it comes to emerging technologies – like cell and gene therapies (CGTs). The hype cycle employs a graph to present the maturity of new technologies as they pass through five...
by Lyla El-Fayomi | Nov 19, 2024
Millions of placentas are discarded annually around the world. Given the regenerative medical potential demonstrated by placenta-derived tissue over the years, this is quite an unfortunate statistic. First used in 1910, placenta-derived tissue was abandoned in the...
by Lyla El-Fayomi | Nov 14, 2024
I’ve once again divided up the October edition of RMNU🔬 by trending research topic. Read on for remarkable placental science, new research involving in vivo genetic engineering, and more! Trend of the month: Healing via placenta Millions of placentas are discarded...
by Medicine by Design | Oct 18, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This portrait is one in a series of portraits that feature “people of Medicine by Design.” Some minor...
by Lyla El-Fayomi | Oct 10, 2024
“Regenerative medicine news under the microscope” is a monthly feature highlighting a selection of impactful research findings and headlines across the many subfields of regenerative medicine. Fall is finally here! September really delivered – lots of interesting...
by Laya Kiani | Sep 26, 2024
The regenerative medicine (RM) market is highly competitive, with major biopharmaceutical companies and innovative startups vying for dominance. As companies seek regulatory approval and work to establish their presence in this fast-evolving industry, the competitive...
Comments